Practical considerations and guidelines for dosing sulfonylureas as monotherapy or combination therapy.

Author: BellDavid S H

Paper Details 
Original Abstract of the Article :
Oral antidiabetic agents are the initial and most commonly used therapy for type 2 diabetes mellitus. To effectively utilize the oral antidiabetic agents, familiarity with the efficacy and side effects of each agent is essential so that strategies for effective therapy with 1 or more agents can be d...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/j.clinthera.2004.10.014

データ提供:米国国立医学図書館(NLM)

Optimizing Sulfonylurea Therapy for Type 2 Diabetes

Just as a camel navigates a desert landscape, choosing the most suitable path, managing type 2 diabetes requires a thoughtful approach. This paper provides practical considerations and guidelines for dosing sulfonylureas, a class of oral antidiabetic agents, as monotherapy or combination therapy. The authors, like skilled desert guides, offer insights into the efficacy and side effects of sulfonylureas, helping healthcare professionals make informed decisions about treatment strategies.

Tailoring Treatment to Individual Needs

The paper emphasizes the importance of individualized treatment strategies, taking into account a patient's specific needs and response to therapy. The authors highlight the need for careful monitoring and adjustments to sulfonylurea dosage to achieve optimal glycemic control and minimize potential side effects.

Managing Diabetes and Maintaining Health

This paper provides valuable information for healthcare professionals and patients alike, offering insights into effective diabetes management strategies. It underscores the importance of individualized treatment plans and the need for close monitoring to achieve optimal health outcomes.

Dr. Camel's Conclusion

This paper sheds light on the complexities of sulfonylurea therapy, highlighting the need for tailored treatment approaches based on individual needs and responses. By understanding the nuances of this class of medication, healthcare professionals can optimize treatment strategies for type 2 diabetes patients, promoting better glycemic control and overall well-being.

Date :
  1. Date Completed 2005-03-29
  2. Date Revised 2009-11-03
Further Info :

Pubmed ID

15639686

DOI: Digital Object Identifier

10.1016/j.clinthera.2004.10.014

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.